Dmitriev noted that out of 110 production sites that negotiated production of Sputnik V, RDIF chose 10 that meet its requirements. "The Russian Sputnik V will be actively produced in the world and we see that this is built on a safe platform based on the human adenovirus," Dmitriev said.
India may produce around 300 million doses of Russia's Sputnik V coronavirus vaccine in 2021, says Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF).
Russia's Sputnik V vaccine is 91.4 per cent effective in providing protection against COVID-19 and has demonstrated 100 per cent efficacy against severe coronavirus cases, the vaccine's developers said on Monday.
Russia's Sputnik V vaccine is likely to offer two-year-long protection against Covid-19, Alexander Gintsburg, the head of the vaccine's developer, Gamaleya National Research Center for Epidemiology and Microbiology, has claimed.
The Oxford University and AstraZeneca COVID-19 vaccine, currently awaiting regulatory approvals, is set to be used for a “mix and match” trial with Russia’s Sputnik vaccine against the novel coronavirus, according to UK media reports.
Russian officials have advised citizens to avoid drinking alcohol for two months after getting the Sputnik V vaccine shot. Russian Deputy Prime Minister Tatiana Golikova said that people will have to observe extra precautions during the 42 days it takes for the Sputnik V coronavirus vaccine to become effective.
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday.
Recently, RDIF had announced the second interim analysis of clinical trial data, which showed 91.4 per cent efficacy for the vaccine on day 28 after the first dose; and efficacy of over 95 per cent 42 days after the first dose.
Top News
Latest News
